期刊文献+

壳聚糖-恶丙嗪缓释片的研制 被引量:4

Preparation of Chitosan-oxaprozin Sustained Release Tablets
暂未订购
导出
摘要 目的:研究壳聚糖-恶丙嗪缓释片的制备、质量标准,并考察体外释药性能。方法:采用紫外分光光度法测定主药恶丙嗪的含量。结果:线性范围为2.5~15.0ug/ml,平均回收率为99.79%,RSD为0.38%。结论:该制剂制备工艺简单,值得临床推广应用。 OBJECTIVE: To study the preparation and quality standard of chitosan-oxaprozin sustained release tablets, and observe the rule of in vitro release of oxaprozin. METHODS:The content of oxaprozin in the tablets was determined by UV - spectrophotometry. RESULTS:The linear range was 2. 5- 15. 0ug/ml. The average recovery was 99. 79% with a RSD of 0. 38%. CONCLUSION: The preparation process of chitosan-oxaprozin sustained release tablet is simple. It is worth expanding the app- lication in clinical practice.
出处 《中国药房》 CAS CSCD 2001年第9期532-533,共2页 China Pharmacy
关键词 壳聚糖 恶丙嗪 缓释片 质量控制 制备 chitosan oxaprozin sustained release tablet preparation quality control
  • 相关文献

参考文献3

共引文献40

同被引文献67

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部